common
caus
vap
gramposit
bacteria
staphylococcu
aureu
methicillin
resist
aureu
mrsa
repres
aureu
isol
vap
vapcaus
pathogen
includ
aerob
gramneg
bacilli
pseudomona
aeruginosa
klebsiella
pneumonia
escherichia
coli
enterobact
speci
acinetobact
speci
stenotrophomona
maltiphila
legionella
pneumophila
oblig
intracellular
bacteri
pathogen
etiolog
agent
commun
acquir
pneumonia
cap
hap
vap
virus
fungi
unusu
caus
vap
although
organ
modul
innat
mucos
respons
predispos
develop
vap
bacteri
pathogen
caus
vap
similar
caus
hap
nonintub
patient
vap
frequent
caus
pathogen
intrins
resist
multipl
antimicrobi
agent
includ
p
aeruginosa
acinetobact
speci
maltiphila
mrsa
mortal
consider
higher
patient
vap
due
p
aeruginosa
strain
express
type
iii
secret
system
requir
secret
pseudomon
exotoxin
u
royburman
et
al
sadikot
et
al
recent
disturb
trend
increas
preval
commun
acquir
stain
mrsa
camrsa
caus
nosocomi
infect
includ
vap
kashuk
et
al
camrsa
typic
strain
produc
array
exotoxin
promot
extens
tissu
necrosi
caviti
format
intrins
antibiot
resist
gramposit
gramneg
bacteri
strain
contribut
increas
mortal
patient
vap
fujitani
et
al
howev
pathogen
gener
less
virul
invas
pathogen
caus
pneumonia
otherwis
healthi
individu
commun
tend
invas
host
anatom
defect
respiratori
tract
substanti
impair
lung
mucos
innat
immun
therefor
presenc
bacteri
speci
pathogen
identi
fi
es
patient
profound
anatom
defect
defect
lung
innat
immun
vast
major
vap
case
develop
result
microaspir
bacteria
colon
oropharynx
american
thorac
societi
infecti
diseas
societi
america
oropharyng
colon
occur
rapidli
critic
ill
patient
exampl
nearli
patient
underli
lung
diseas
andor
undergo
oropharyng
intub
found
colon
pathogen
bacteria
within
h
admiss
intens
care
unit
garrousteorgea
et
al
reservoir
contribut
oropharyng
colon
includ
nasopharynx
sinus
stomach
endotrach
tube
contribut
colon
directli
injur
mucos
surfac
upper
respiratori
tract
facilit
bacteri
adhes
organ
caus
vap
includ
p
aeruginosa
aureu
promot
bio
fi
lm
format
endotrach
tube
lumen
function
nidu
direct
inocul
infect
materi
distal
airspac
less
common
sourc
bacteri
inocul
includ
colon
ventil
circuit
direct
inocul
via
infect
aerosol
instrument
particularli
suction
cathet
bronchoscop
comparison
hematogen
seed
lung
caus
vap
consider
less
common
account
case
notabl
except
hematogen
seed
intravascular
aureu
infect
gut
bacteri
transloc
occur
immunocompromis
patient
neutropenia
microaspir
common
event
healthi
critic
ill
patient
event
rare
result
infect
healthi
subject
primarili
due
highli
effect
mean
erad
infecti
toxic
insult
respiratori
tract
includ
ef
fi
cient
mucocilliari
clearanc
mechan
robust
innat
mucos
antimicrobi
respons
mechan
ventil
patient
impair
mucocilliari
transport
innat
cellular
respons
result
establish
pulmonari
infect
summari
factor
contribut
pathogenesi
vap
shown
fig
ciliat
pseudostrati
fi
ed
columnar
epitheli
cell
line
tracheobronchi
tree
ciliat
cell
critic
effect
mucocilliari
transport
cephalad
movement
mucou
microb
acellular
debri
present
within
conduct
airway
damag
ciliat
cell
occur
direct
result
endotrach
intub
end
result
combin
host
factor
medic
instrument
introduct
infecti
materi
steril
lung
environ
factor
along
immun
state
host
contribut
develop
vap
condit
predispos
patient
respiratori
failur
nichol
et
al
piatti
et
al
pittet
et
al
discuss
previous
denud
columnar
epitheli
cell
result
endotrach
tube
endotrach
tube
cuff
moreov
lung
condit
result
mechan
ventil
copd
associ
impair
mucocilliari
transport
piatti
et
al
moreov
certain
form
infecti
lung
injuri
includ
sever
acut
respiratori
syndrom
sar
character
bronchial
epitheli
denud
loss
cilia
nichol
et
al
similarli
fl
uenza
infect
predispos
secondari
bacteri
infect
due
impair
lung
innat
respons
also
disrupt
mucocilliari
transport
mechan
pittet
et
al
mani
form
critic
ill
result
profound
state
immun
suppress
affect
cellular
acquir
arm
host
immun
syndrom
immun
suppress
best
character
perhap
sever
sepsi
also
describ
trauma
patient
burn
injuri
patient
patient
periop
period
sepsi
complex
clinic
syndrom
result
interact
microb
host
clinic
de
fi
ned
system
fl
ammatori
respons
syndrom
sir
evid
infect
member
american
colleg
chest
physicianssocieti
critic
care
medicin
chang
popul
risk
develop
sepsi
includ
increas
number
elderli
immunocompromis
patient
result
steadi
rise
incid
sever
sepsi
martin
et
al
despit
improv
support
care
immunomodulatori
therapi
mortal
rate
sever
sepsi
remain
unaccept
high
brunbuisson
host
immun
respons
critic
ill
includ
sepsi
conceptu
occur
distinct
overlap
phase
initi
respons
critic
ill
refer
system
fl
ammatori
respons
syndrom
sir
character
releas
number
proin
fl
ammatori
mediat
includ
earli
respons
cytokin
tumor
necrosi
factoralpha
tnfa
b
b
interleukin
leukocyteact
chemokin
adhes
molecul
fl
ammatori
leukotrien
dinarello
sir
counterregul
releas
inhibitori
molecul
includ
antiin
fl
ammatori
cytokin
eg
interleukin
transform
growth
factorbeta
tgfb
suppressor
pathogen
recognit
signal
cascad
immunomodulatori
prostanoid
hormon
counterregulatori
phase
refer
compensatori
antiin
fl
ammatori
respons
syndrom
car
wesch
et
al
bone
molecul
releas
car
believ
serv
function
brake
system
fl
ammat
express
mediat
induc
microbialderiv
hostderiv
signal
sir
car
overlap
consider
henc
overal
immun
statu
patient
depend
respons
predomin
fig
van
der
poll
van
devent
recent
evid
suggest
third
respons
fl
ammatori
insult
refer
mix
antagonist
respons
syndrom
mar
respons
character
secret
proand
antiin
fl
ammatori
mediat
speci
fi
calli
monocyt
chemotact
protein
mcp
macrophag
fl
ammatori
protein
mip
b
ifng
granulocytemacrophag
coloni
stimul
factor
gmcsf
tamayo
et
al
consist
mix
system
cytokin
respons
elev
level
circul
shown
predict
develop
vap
ramirez
et
al
whether
initi
sir
respons
drive
express
molecul
contribut
immun
suppress
simpli
marker
system
fl
ammat
remain
determin
summari
innat
immun
event
critic
ill
shown
fig
compensatori
releas
antiin
fl
ammatori
molecul
sepsi
believ
mediat
immunosuppress
perisept
postinjuri
period
time
immun
cell
function
substanti
impair
histor
refer
critic
illnessinduc
leukocyt
deactiv
immunoparalysi
recent
sinc
alter
leukocyt
phenotyp
critic
ill
involv
select
regul
innat
gene
phenomenon
appropri
refer
reprogram
leukocyt
reprogram
appear
consider
clinic
signi
fi
canc
higher
rate
nosocomi
infect
increas
mortal
observ
postop
burn
injuri
septic
patient
display
evid
monocyt
deactiv
either
form
decreas
monocyt
hladr
express
ex
vivo
cytokin
product
impair
delayedtyp
hypersensit
respons
appel
et
al
munoz
et
al
septic
patient
especi
suscept
nosocomi
infect
lung
particularli
pneumonia
multidrugresist
gramposit
gramneg
organ
includ
aureu
p
aeruginosa
richardson
et
al
mustard
et
al
sepsisinduc
immunosuppress
particularli
promin
patient
preexist
de
fi
cienci
innat
acquir
immun
includ
elderli
patient
chronic
medic
condit
hotchkiss
karl
patient
undergo
sever
stress
includ
trauma
massiv
hemorrhag
burn
injuri
postsurgeri
sepsi
exhibit
signi
fi
cant
defect
circul
resid
leukocyt
popul
addit
chang
pulmonari
microenviron
occur
result
mechan
ventil
substanti
fl
uenc
lung
innat
respons
multipl
leukocyt
subtyp
affect
speci
fi
c
defect
shown
fig
sepsi
similar
stressassoci
event
shown
fl
uenc
effector
activ
varieti
immun
cell
major
studi
focus
peripher
blood
monocyt
pbm
lesser
extent
tissu
macrophag
chang
monocytemacrophag
function
sepsi
resembl
ident
observ
endotoxintoler
macrophag
endotoxin
toler
describ
phenomena
wherebi
upon
initi
exposur
lp
cell
becom
refractori
secondari
stimulu
lp
pathogenassoci
molecular
pattern
pamp
lp
also
induc
toler
phenotyp
pamp
one
type
induc
cross
toler
differ
pamp
induct
toler
result
suppress
multipl
fl
ammatori
gene
includ
nfk
b
mitogenactiv
protein
kinas
mapk
depend
gene
eg
tnfa
ino
toler
caus
global
suppress
gene
gene
encod
certain
antimicrobi
phagocyt
protein
includ
cathelicidin
antimicrobi
peptid
lipocalin
scaveng
receptor
marco
fmlp
receptor
inde
superinduc
respons
sequenti
exposur
lp
foster
et
al
also
noteworthi
induct
phenotyp
restrict
myeloid
cell
structur
cell
includ
alveolar
epitheli
cell
shown
develop
toler
respons
upon
repeat
exposur
pamp
lp
pamp
toler
phenotyp
transient
natur
entir
revers
associ
remodel
chromatin
promot
region
sever
toleriz
gene
foster
et
al
chan
et
al
critic
ill
like
endotoxin
toler
lead
inhibit
broad
rang
nfk
bdepend
fl
ammatori
gene
monocyt
notabl
signi
fi
cant
reduct
ex
vivo
product
fl
ammatori
cytokin
includ
b
tnfa
observ
monocyt
isol
patient
sepsi
munoz
et
al
chang
cytokin
product
may
predictor
outcom
peripher
monocyt
isol
surviv
sepsi
regain
abil
produc
cytokin
respons
lp
stimul
varieti
cellular
bacteri
mechan
mediat
contribut
impair
innat
acquir
immun
respons
critic
ill
upward
arrow
repres
effect
enhanc
expressionfunct
downward
arrow
repres
effect
reduc
expressionfunct
monocyt
isol
nonsurvivor
munoz
et
al
convers
product
certain
antiin
fl
ammatori
protein
includ
receptor
antagonist
tnf
solubl
receptor
ii
enhanc
monocyt
isol
sepsi
patient
patient
ventilatorinduc
lung
injuri
frank
et
al
patient
sepsi
earli
trauma
reduc
monocyt
hladr
express
appel
et
al
adibconquy
et
al
reduct
hladr
express
report
directli
correl
magnitud
sepsi
volk
et
al
may
partial
contribut
impair
cellmedi
immun
observ
patient
critic
ill
similar
critic
illnessinduc
defect
note
macrophag
resid
variou
tissu
instanc
associ
evid
enhanc
macrophag
apoptosi
ayala
et
al
gallinaro
et
al
particular
alveolar
macrophag
function
shown
impair
set
sepsi
exampl
alveolar
macrophag
recov
mice
abdomin
sepsi
cecal
ligat
punctur
display
reduc
product
fl
ammatori
cytokin
chemokin
eicosanoid
nitric
oxid
respiratori
burst
reddi
et
al
goya
et
al
importantli
phenotyp
alter
alveolar
macrophag
effector
function
associ
markedli
enhanc
suscept
intrapulmonari
challeng
gramposit
gramneg
bacteri
pathogen
steinhaus
et
al
deng
et
al
littl
known
alveolar
macrophag
phenotyp
critic
ill
patient
risk
develop
vap
howev
perform
affymetrix
microarray
analysi
adher
puri
fi
ed
alveolar
macrophag
recov
patient
sepsisinduc
ali
within
day
onset
sepsi
rel
alveolar
macrophag
recov
healthi
subject
lung
macrophag
sepsisinduc
ali
patient
display
hybrid
tolerizedaltern
activ
phenotyp
character
minim
chang
suppress
nfk
bdepend
gene
eg
tnfa
b
ino
induct
antimicrobi
gene
antimicrobi
peptid
chemoattract
phagocytosi
gene
express
maker
altern
rather
classic
activ
high
arginas
mmp
express
low
ino
interferong
ifninduc
chemokin
express
gordon
martinez
although
express
pattern
may
partial
fl
ect
lung
injuri
respons
like
phenotyp
shape
system
fl
ammat
alter
neutrophil
pmn
resembl
describ
monocyt
macrophag
present
septic
respons
predict
advers
outcom
patient
system
fl
ammat
promot
cytoskelet
chang
pmn
cell
membran
rigid
reduc
cellular
deform
result
impair
recruit
site
infect
deleteri
accumul
activ
pmn
vascular
bed
distant
organ
direct
migrat
also
impair
nitric
oxidemedi
inhibit
icam
vcamdepend
adhes
transmigr
pmn
downregul
chemokin
receptor
inhibit
gprotein
coupl
receptor
signal
benjamim
et
al
cum
et
al
czermak
et
al
huberlang
et
al
swartz
et
al
microarray
analysi
pmn
isol
septic
patient
within
h
onset
reveal
global
suppress
immun
regul
fl
ammatori
respons
gene
cluster
particularli
gene
regul
nfk
bdepend
fashion
tang
et
al
convers
express
select
suppress
gene
enhanc
includ
nfk
b
inhibitor
nf
k
bia
discoveri
neutrophil
extracellular
trap
net
provid
yet
anoth
role
neutrophil
contain
infect
net
complex
structur
compos
nuclear
chromatin
histon
varieti
granular
antimicrobi
protein
cytoplasm
protein
urban
et
al
format
occur
respons
exposur
neutrophil
plasma
septic
patient
clark
et
al
well
direct
contact
microbi
pathogen
remijsen
et
al
neutrophil
elastas
releas
azurophil
granul
assist
format
net
via
decondens
nuclear
chromatin
along
serin
proteas
confer
antimicrobi
respons
papayannopoulo
et
al
netassoci
myeloperoxidas
directli
contribut
bacteri
kill
staphylococcu
aureu
presenc
h
parker
et
al
net
capabl
physic
ensnar
bacteria
facilit
interact
bacteria
antimicrobi
effector
ultim
lead
enhanc
bacteri
kill
mantovani
et
al
despit
broad
antimicrobi
capac
bacteria
express
nucleas
degrad
net
thu
avoid
captur
bacteri
cell
death
buchanan
et
al
berend
et
al
young
et
al
case
net
may
exert
detriment
effect
host
increas
evid
link
net
format
excess
fl
ammat
tissu
damag
diseas
sepsi
clark
et
al
net
format
recent
demonstr
alveoli
mice
fl
uenza
pneumonia
structur
contribut
acut
lung
injuri
respons
anim
narasaraju
et
al
presenc
net
clearli
establish
experiment
bacteri
pneumonia
patient
vap
tempt
specul
structur
may
contribut
lung
injuri
occur
set
dendrit
cell
dc
ef
fi
cient
profession
antigenpres
cell
apc
lung
uniqu
abil
induc
primari
immun
respons
cell
dc
preval
central
within
spleen
lymphat
mucos
surfac
notabl
gut
respiratori
tract
system
endotoxin
administr
mice
result
brisk
deplet
splenic
dc
h
postlp
similarli
prolong
loss
dc
day
postinduct
abdomin
sepsi
lung
spleen
wen
et
al
human
lethal
sepsi
follicular
dc
substanti
diminish
earli
cours
diseas
hotchkiss
et
al
similarli
reduct
blood
myeloid
dc
plasmacytoid
dc
control
respect
observ
patient
admit
hospit
pneumonia
number
dc
invers
correl
procalcitonin
level
marker
system
fl
ammat
dreschler
et
al
endotoxintoler
dc
dc
isol
anim
human
sepsi
produc
low
level
tnfa
high
level
wen
et
al
wysocka
et
al
shift
cytokin
pro
fi
le
persist
week
postabdomin
sepsi
clp
associ
posttransl
epigenet
modi
fi
cation
histon
bind
promot
increas
suscept
pulmonari
fungal
challeng
wen
et
al
regulatori
dc
tolerogen
dc
newli
describ
dc
popul
induc
incub
bone
marrowderiv
dc
result
dc
preferenti
secret
rather
induc
cell
toler
natur
occur
dc
reg
popul
identi
fi
ed
spleen
low
high
adopt
transfer
cell
popul
septic
mice
diminish
fl
ammatori
cytokin
product
sepsisinduc
lethal
fujita
et
al
chang
number
distribut
function
cell
lung
especi
critic
ill
yet
explor
like
leukocyt
popul
variou
lymphocyt
popul
fl
uenc
like
contribut
immunosuppress
effect
critic
ill
effect
directli
due
chang
lymphocyt
number
effector
function
indirectli
due
chang
apc
function
notabl
dc
studi
consist
show
sepsi
state
extrem
stress
trauma
burn
injuri
gener
result
anergi
shift
cell
cytokin
respons
favor
rather
respons
sepsi
trauma
critic
state
result
substanti
drop
number
circul
lymphocyt
lymphopenia
develop
earli
insult
persist
magnitud
lymphopenia
correl
risk
nosocomi
infect
death
hotchkiss
et
al
autopsi
studi
septic
patient
reveal
profound
loss
splenic
b
cell
cell
follicular
dendrit
cell
alter
number
cell
observ
loss
b
cell
mediat
apoptosi
similar
chang
although
uniform
could
observ
critic
ill
patient
without
sepsi
hotchkiss
et
al
addit
chang
absolut
number
lymphocyt
septic
respons
induc
consider
alter
lymphocyt
effector
function
instanc
memoryeffector
lymphocyt
subset
nonsurviv
septic
patient
demonstr
signi
fi
cantli
decreas
ifng
synthesi
compar
survivor
zedler
et
al
similarli
cell
prolif
respons
cytokin
product
tnfa
signi
fi
cantli
depress
patient
abdomin
sepsi
compar
healthi
control
degre
tnfa
suppress
directli
correl
patient
surviv
heideck
et
al
proport
cell
increas
patient
sepsi
nonsept
critic
ill
control
patient
healthi
subject
ferguson
et
al
similar
observ
made
anim
model
sepsi
splenocyt
isol
mice
undergo
clp
produc
less
ifng
splenocyt
isol
healthi
anim
ayala
et
al
osullivan
et
al
given
import
phenotyp
respons
host
defens
intracellular
extracellular
microbi
pathogen
shift
away
appropri
toward
dysregul
respons
obviou
implic
antimicrobi
host
immun
regulatori
cell
treg
limit
import
popul
cell
univers
express
transcript
factor
forkhead
box
treg
inhibit
cell
effector
function
result
neg
regul
innat
acquir
immun
respons
suppress
effect
treg
mediat
direct
cellcel
contact
releas
solubl
mediat
includ
limit
tgfb
increas
percentag
absolut
number
treg
found
blood
lymphat
spleen
septic
mice
human
sepsi
trauma
venet
et
al
scumpia
et
al
wisnoski
et
al
moreov
evid
enhanc
express
suppress
function
treg
mice
abdomin
sepsi
adopt
transfer
treg
septic
mice
reduc
overzeal
tnfa
product
improv
mortal
howev
deplet
treg
mice
polymicrobi
sepsi
littl
impact
sepsisinduc
mortal
scumpia
et
al
wisnoski
et
al
thu
role
treg
control
system
fl
ammatori
respons
mediat
impair
innat
acquir
immun
critic
ill
patient
risk
vap
uncertain
requir
studi
recent
describ
b
cell
may
play
critic
role
innat
respons
local
system
infect
rauch
et
al
innat
respons
activ
b
irab
cell
popul
cell
produc
larg
quantiti
gmcsf
infect
popul
expand
bone
marrow
spleen
respons
system
lp
administr
abdomin
sepsi
genet
delet
cell
result
mark
reduct
system
cytokin
respons
gmcsf
express
abil
clear
abdomin
polymicrobi
infect
microb
microbi
compon
initi
septic
respons
recogn
cell
surfac
intracellular
pathogen
recognit
receptor
prr
includ
tolllik
receptor
tlr
nucleotidebind
oligomer
domain
nod
like
receptor
nlr
tolllik
receptor
famili
evolutionarili
conserv
type
transmembran
receptor
respond
pamp
express
divers
group
infecti
microorgan
result
activ
host
immun
system
aderem
ulevitch
akira
hemmi
exist
distinct
tlr
human
mice
common
extracellular
domain
leucin
rich
repeat
intracytoplasm
domain
share
receptor
bind
ligand
tlr
initi
signal
cascad
involv
myeloid
differenti
marker
kinas
irak
tnfrassoci
factor
result
nfk
b
transloc
mapk
activ
culmin
express
gene
involv
antimicrobi
host
defens
aderem
ulevitch
akira
hemmi
addit
certain
tlr
initi
signal
cascad
requir
adaptor
protein
receptor
domain
contain
adaptor
protein
induc
interferon
trif
trifrel
adaptor
molecul
tram
result
express
interferon
respons
gene
relev
tlr
lung
antibacteri
host
defens
includ
recogn
speci
fi
c
compon
gramposit
bacteria
fungi
major
receptor
lp
recogn
activ
bacteri
fl
agellin
activ
unmethyl
cpg
motif
present
microbi
mammalian
dna
addit
pamp
tlr
activ
hostderiv
danger
signal
refer
damageassoci
molecular
pattern
damp
alarmin
includ
heat
shock
protein
matrix
compon
ohashi
et
al
also
highmobl
group
box
protein
molecul
releas
septic
respons
recent
shown
activ
park
et
al
particular
relev
set
sepsi
acut
lung
injuri
multipl
tlr
particip
lung
host
immun
gramneg
bacteria
exampl
recogn
lipid
moieti
lp
major
tlr
mediat
earli
innat
respons
clearanc
nonfl
agel
gramneg
organ
caus
vap
includ
k
pneumonia
h
fl
uenza
e
coli
schurr
et
al
bhan
et
al
wieland
et
al
addit
mice
de
fi
cient
display
impair
dendrit
cellmedi
respons
experiment
klebsiella
legionella
pneumonia
culmin
reduc
lung
bacteri
clearanc
decreas
surviv
bhan
et
al
bhan
et
al
innat
respons
fl
agel
extracellular
bacteria
p
aeruginosa
mediat
sever
tlr
predominantli
hajjar
et
al
ramphal
et
al
skerrett
et
al
interestingli
bone
marrowderiv
stromal
cell
contribut
innat
respons
p
aeruginosa
lung
hajjar
et
al
tolllik
receptor
appear
play
lesser
role
host
defens
aureu
exampl
shown
mediat
fl
ammatori
respons
staphylococc
toxin
pantonvalentin
leukocidin
neither
requir
effect
antistaphylococc
host
immun
respiratori
infect
skerrett
et
al
zivkov
et
al
nucleotidebind
oligodimer
domain
nod
like
receptor
nlr
recogn
peptidoglycan
compon
muramyl
dipeptid
mdp
shown
import
fl
ammatori
cytokin
releas
bacteri
erad
murin
aureu
skin
infect
model
hruz
et
al
inohara
et
al
recent
mice
de
fi
cient
share
adaptor
molecul
consider
suscept
intrapulmonari
challeng
aureu
wildtyp
mice
effect
depend
downstream
activ
fl
b
releas
unpublish
observ
j
deng
later
observ
suggest
nlr
rather
tlr
may
predomin
contributor
antistaphylococc
immun
lung
signal
cascad
studi
identi
fi
ed
chang
cell
surfac
express
variou
tlr
septic
respons
particular
either
enhanc
reduc
cell
surfac
express
describ
monocyt
sepsi
patient
tissu
macrophag
experiment
sepsi
deng
et
al
brunialti
et
al
moreov
chang
monocyt
cell
surfac
express
lp
bind
partner
also
observ
sepsi
brunialti
et
al
wolf
et
al
william
et
al
dispar
fi
nding
like
attribut
tempor
differ
assess
tlr
express
heterogen
patient
popul
studi
anim
model
employ
extracellular
domain
certain
tlr
shed
activ
macrophag
serv
sink
bind
extracellular
pamp
consequ
dampen
tlrmediat
signal
transduct
instanc
solubl
releas
human
peripher
blood
monocyt
pbm
diminish
cellular
respons
agonist
without
affect
cellular
respons
lp
leboud
et
al
natur
occur
recombin
solubl
shown
diminish
respons
lp
iwami
et
al
hyakushima
et
al
contribut
solubl
impair
innat
respons
critic
ill
remain
determin
illumin
import
tlr
lung
innat
immun
critic
ill
combin
loss
function
polymorph
adaptor
tirapm
homozyg
tirapm
polymorph
causal
link
reduc
circul
fl
ammatori
cytokin
level
reduc
ex
vivo
monocyt
cytokin
express
increas
risk
seriou
postop
infect
includ
vap
ferwerda
et
al
molecul
identi
fi
ed
inhibit
tlr
signal
multipl
site
downstream
receptor
receptorassoci
kinas
irak
key
kinas
necessari
receptormedi
signal
transduct
consequ
interrupt
phosphoryl
traf
fi
cking
profound
effect
downstream
express
nfk
b
mapkdepend
fl
ammatori
antimicrobi
gene
receptorassoci
kinasem
irakm
also
name
member
irak
famili
howev
irakm
differ
protein
lack
kinas
activ
irakm
shown
neg
regul
tlr
signal
block
disassoci
signal
domain
bone
marrowderiv
lung
macrophag
lack
irakm
display
enhanc
mapk
kinas
activ
fl
ammatori
cytokin
product
respons
tlr
agonist
live
bacteria
wesch
et
al
kobayashi
et
al
importantli
irakm
induc
endotoxin
ligand
muramyl
dipeptid
mdp
pamp
requir
develop
toler
endotoxin
peptidoglycan
kobayashi
et
al
hedl
et
al
nakayama
et
al
found
irakm
upregul
alveolar
macrophag
experiment
sepsi
fashion
mediat
suppress
macrophag
cytokin
respons
impair
lung
clearanc
p
aeruginosa
septic
mice
deng
et
al
lynkew
et
al
irakm
also
shown
suppress
tlrmediat
respons
murin
primari
alveolar
epitheli
cell
seki
et
al
emerg
data
suggest
irakm
may
major
mediat
perhap
biomark
sever
diseas
sepsi
irakm
substanti
induc
monocyt
healthi
subject
administ
lp
intraven
va
nt
veer
et
al
patient
gramneg
sepsi
blood
monocyt
demonstr
rapid
robust
express
irakm
stimul
ex
vivo
lp
escol
et
al
addit
enhanc
express
irakm
mrna
note
pediatr
patient
sepsi
high
irakm
mrna
level
associ
longer
length
intens
care
unit
icu
stay
need
mechan
ventil
death
hall
et
al
also
observ
high
constitut
express
irakm
mrna
alveolar
macrophag
peripher
blood
buffi
coat
cell
isol
patient
sepsisinduc
ali
compar
similar
cell
popul
healthi
subject
standiford
unpublish
observ
fact
irakm
neg
regul
tlr
signal
found
signi
fi
cantli
induc
patient
popul
sever
molecul
causal
link
develop
endotoxin
toler
hyperin
fl
ammatori
respons
lp
genet
de
fi
cient
mice
suppress
tumorigen
transmembran
protein
solubl
secret
protein
express
varieti
cell
includ
cell
macrophag
inhibit
signal
interf
abil
maltirap
interact
downstream
signal
molecul
protein
appear
contribut
sepsisinduc
impair
lung
antibacteri
defens
least
anim
model
holub
et
al
speci
fi
calli
clpinduc
impair
antipseudomon
lung
host
defens
revers
mice
de
fi
cient
interestingli
respons
alter
wherea
express
ifng
tnfa
cell
preserv
mice
set
abdomin
sepsi
compar
similarli
treat
wildtyp
anim
tolllik
receptor
signal
also
modul
extracellular
intracellular
decoy
singl
immunoglobulin
protein
sigirr
member
receptor
superfamili
unabl
signal
howev
extracellular
domain
molecul
inhibit
signal
interf
bind
ligand
receptor
wherea
intracellular
domain
interfer
complex
thomassen
et
al
wald
et
al
qin
et
al
sigirr
express
predominantli
epitheli
cell
includ
alveolar
epitheli
cell
also
lesser
degre
monocyt
popul
mice
de
fi
cient
sigirr
enhanc
fl
ammatori
respons
lp
challeng
moreov
sigirr
upregul
pbm
septic
patient
associ
develop
endotoxin
toler
cell
adibconquy
et
al
short
altern
splice
variant
parent
molecul
function
domin
neg
molecul
block
recruit
signal
domain
result
reduc
phosphoryl
burn
et
al
rao
et
al
express
induc
monocyt
respons
lp
constitut
express
blood
monocyt
isol
patient
sepsi
adibconquy
et
al
tollip
disrupt
interact
wherea
microrna
mirna
posttranscript
inhibit
express
nahid
et
al
suppressor
cytokin
signal
soc
famili
molecul
predomin
inhibit
jakstat
signal
also
disrupt
tlr
signal
cascad
yet
und
fi
ned
mechan
latter
molecul
could
contribut
suppress
tlrmediat
respons
critic
ill
data
show
enhanc
express
andor
activ
blood
monocyt
lung
macrophag
patient
risk
develop
vap
initi
mechan
ventil
mv
vital
therapeut
intervent
patient
respiratori
failur
consequ
mechan
ventil
inhomogen
distribut
pressur
volum
variou
region
lung
result
excess
stretch
alveolar
unit
refer
volutrauma
repeat
alveolar
collaps
region
refer
atelectotrauma
pugin
et
al
excess
lung
stretch
result
activ
sever
transcript
pathway
includ
nfkb
mapk
kinas
pathway
fo
jun
contribut
releas
variou
fl
ammatori
mediat
tnfa
b
gharib
et
al
halbertsma
et
al
jaecklin
et
al
cellular
mediat
trigger
deleteri
lung
injuri
respons
possibl
multipl
organ
dysfunct
may
also
promot
reprogram
leukocyt
structur
cell
occur
critic
ill
importantli
mv
moder
high
lung
volum
also
prime
lung
enhanc
lung
injuri
system
organ
failur
respons
infecti
challeng
eg
second
hit
instanc
compar
spontan
breath
anim
intrapulmonari
administr
aureu
e
coli
mechan
ventil
mice
result
enhanc
lung
fl
ammat
lung
injuri
without
chang
lung
bacteri
clearanc
likewis
ip
administr
lp
mice
undergo
high
tidal
volum
mv
substanti
increas
lung
system
cytokin
express
extrapulmonari
organ
injuri
compar
nonmechan
ventil
control
mechan
account
synergist
interact
lung
stretch
infecti
challeng
clearli
de
fi
ned
howev
previou
work
shown
stretch
human
alveolar
epitheli
cell
increas
express
sixfold
charl
et
al
moreov
mechan
ventil
increas
rel
express
lung
tissu
increas
gener
endogen
ligand
bronchoalveolar
lavag
fl
uid
vanek
et
al
recent
work
shown
mechan
ventil
also
gener
endogen
tlr
ligand
chun
et
al
hyperin
fl
ation
lung
high
tidal
volum
promot
signi
fi
cant
increas
express
also
paradox
induc
express
irakm
import
neg
regul
tlr
signal
villar
et
al
frequent
consequ
mechan
ventil
diseas
caus
acut
respiratori
failur
alveolar
collaps
atelectasi
alveolar
collaps
due
part
reduct
surfact
occur
patient
receiv
mechan
ventil
patient
vap
nako
et
al
atelectasi
shown
promot
bacteri
overgrowth
use
open
ventil
strategi
administr
exogen
surfact
reduc
bacteri
number
anim
model
vap
van
kaam
et
al
moreov
administr
posit
endexpiratori
pressur
peep
cmh
nonhypoxem
mechan
ventil
patient
reduc
incid
vap
manzano
et
al
surfact
protein
agglutin
p
aeruginosa
spd
serv
opsonin
enhanc
phagocytosi
p
aeruginosa
mccormack
pseudomon
elastas
shown
degrad
spa
spd
protein
decreas
lung
patient
cystic
fi
brosi
mariencheck
et
al
howev
chang
spa
spd
level
mechan
ventil
andor
vap
well
character
administr
high
concentr
oxygen
fio
use
transient
prolong
mechan
ventil
common
treatment
patient
respiratori
failur
gore
et
al
although
therapeut
necessari
hyperoxia
result
gener
reactiv
oxygen
speci
ro
promot
breakdown
critic
barrier
lead
system
cellular
organ
injuri
lee
choi
lung
ro
caus
sever
cellular
damag
death
exposur
basement
membran
disrupt
alveolar
capillari
membran
lead
increas
pulmonari
permeabl
fl
ux
fl
ammatori
cell
impair
ga
exchang
bhandari
elia
hyperox
exposur
also
exacerb
alveolar
epitheli
injuri
apoptosi
respons
infecti
challeng
p
aeruginosa
l
pneumophila
result
increas
bacteri
dissemin
kikuchi
et
al
moreov
high
oxygen
tension
inhibit
function
innat
immun
cell
instanc
macrophag
expos
elev
concentr
oxygen
vitro
vivo
display
reduc
phagocytosi
kill
gramneg
bacteria
correl
chang
cell
morpholog
actin
polymer
oreilli
et
al
addit
vivo
hyperoxia
exposur
increas
suscept
k
pneumonia
lung
infect
effect
partial
attribut
reduc
bal
gmcsf
level
cell
surfac
express
baleeiro
et
al
importantli
system
treatment
mice
gmcsf
hyperoxia
preserv
macrophag
function
decreas
sever
lung
infect
baleeiro
et
al
taken
togeth
hyperoxia
detriment
host
promot
greater
alveolarcapillari
injuri
impair
local
antibacteri
respons
increas
risk
bacteri
dissemin
emerg
clinic
epidemiolog
data
suggest
possibl
link
colon
candida
speci
suscept
p
aeruginosa
pulmonari
infect
candida
speci
among
common
organ
recov
endotrach
tube
bio
fi
lm
tracheal
secret
patient
vap
adair
et
al
histor
candida
consid
commens
organ
rather
true
pathogen
therefor
believ
play
role
vap
diseas
pathogenesi
howev
observ
studi
found
statist
associ
airway
colon
candida
speci
develop
p
aeruginosa
vap
azoulay
et
al
rat
model
p
aeruginosa
pneumonia
prior
bronchial
instil
live
heatkil
c
albican
result
increas
suscept
subsequ
bacteri
challeng
roux
et
al
mechan
account
impair
vivo
clearanc
respons
identi
fi
ed
c
albican
found
inhibit
respiratori
burst
ex
vivo
intrigu
fi
nding
requir
con
fi
rmation
experiment
model
system
rais
possibl
candida
perhap
commens
organ
may
contribut
meaning
vap
pathogenesi
antibiot
prophylact
measur
reduc
oropharyng
colon
microaspir
approach
stimul
mucocilliari
transport
mainstay
therapi
prevent
treat
vap
treatment
effect
patient
adjuv
therapi
need
other
bolster
innat
host
respons
especi
elderli
patient
chronic
immunosuppress
therapi
recognit
critic
ill
induc
profound
state
immun
dysregul
prompt
reevalu
potenti
immunolog
approach
use
treatment
sepsi
form
critic
ill
pockro
et
al
effect
immunoadjuv
therapi
must
necessarili
promot
antimicrobi
effect
without
exacerb
deleteri
lung
fl
ammatori
respons
common
featur
endotoxin
toler
immun
dysregul
critic
ill
impair
tlr
signal
nfk
bdepend
respons
reduc
apc
function
shift
toward
type
rather
type
immun
respons
two
cytokin
shown
partial
revers
chang
vitro
vivo
ifng
gmcsf
endotoxintoler
monocyt
treatment
ifng
gmcsf
revers
toler
phenotyp
part
facilit
interact
irak
result
enhanc
downstream
activ
nfk
b
adibconquy
cavaillon
similarli
ex
vivo
treatment
blood
monocyt
trauma
patient
ifng
gmcsf
gcsf
enhanc
lpsinduc
cytokin
product
hladr
express
lendeman
et
al
preclin
studi
serv
foundat
sever
small
clinic
trial
patient
sepsi
dock
colleagu
administ
ifng
patient
sepsi
attempt
revers
cytokin
imbal
restor
monocyt
function
dock
et
al
uncontrol
studi
nine
patient
evid
sepsisinduc
immunosuppress
decreas
blood
monocyt
hladr
express
administ
ifng
dose
g
subcutan
daili
treatment
ifng
result
increas
monocyt
hladr
express
patient
along
restor
monocyt
tnfa
product
level
observ
monocyt
isol
healthi
subject
resolut
sepsi
occur
eight
nine
treat
patient
dock
et
al
two
small
singl
center
clinic
trial
iv
administr
hrgmcsf
patient
sepsi
result
improv
ex
vivo
effector
respons
pbm
neutrophil
nierhau
et
al
presneil
et
al
moreov
one
studi
reveal
improv
pao
fio
ratio
measur
pulmonari
ga
exchang
suggest
reduc
lung
injuri
gmcsf
treat
group
presneil
et
al
prevent
lung
injuri
may
due
part
fact
gmcsf
alveolar
epitheli
cell
mitogen
protect
alveolar
epithelium
hyperox
bleomycininduc
injuri
baleeiro
et
al
moor
et
al
murin
model
fl
uenza
pneumonia
severchroneo
et
al
preclin
clinic
fi
nding
serv
basi
multicent
random
placebo
control
trial
subcutan
gmcsf
administr
patient
sever
sepsi
evid
monocyt
deactiv
reduc
hladr
express
compar
placebo
group
gmcsf
administr
result
improv
monocyt
function
restor
cell
surfac
express
tnf
product
hladr
express
improv
clinic
outcom
includ
reduc
apach
ii
score
shorter
time
mechan
ventil
trend
toward
decreas
length
icu
hospit
stay
studi
other
suggest
immunostimulatori
therapi
treatment
critic
illnessinduc
immun
dysregul
even
endorgan
injuri
appear
potenti
viabl
therapeut
option
warrant
larger
control
trial
luedk
cerami
obviou
concern
immunostimulatori
therapi
patient
sever
sepsi
andor
pneumonia
potenti
exacerb
cytokin
storm
sir
fortun
neither
ifng
gmcsf
precipit
worsen
hemodynam
compromis
multiorgan
failur
even
patient
sever
sepsi
septic
shock
dock
et
al
nierhau
et
al
meisel
et
al
addit
consider
could
given
compartment
immunostimulatori
therapi
eg
aerosol
deliveri
prevent
treat
vap
howev
approach
may
limit
substanti
ventilationperfus
mismatch
occur
patient
lung
diseas
concern
leukocyt
reprogram
occur
critic
ill
limit
lung
microenviron
almost
certainli
occur
broadli
leukocyt
popul
system
activ
pathway
certain
leukocyt
popul
lessen
nfk
bmediat
proin
fl
ammatori
respons
stimul
prosurviv
antimicrobi
respons
william
et
al
wrann
et
al
zhang
et
al
exampl
administr
select
activ
signal
pathway
eg
glucan
lipoic
acid
lpschalleng
mice
mice
undergo
clp
reduc
apoptosi
fl
ammatori
cytokin
releas
improv
mortal
wrann
et
al
zhang
et
al
interleukin
pleurapotenti
cytokin
regul
dc
nk
cell
activ
prolifer
surviv
administr
mice
abdomin
sepsi
clp
shown
block
sepsisinduc
apoptosi
nk
cell
dc
cell
restor
nk
cell
product
ifng
inou
et
al
treatment
also
mitig
sepsisinduc
apoptosi
gut
epithelium
importantli
reduc
mortal
clp
also
mice
administ
p
aeruginosa
final
caspas
inhibitor
shown
reduc
lymphocyt
apoptosi
increas
surviv
murin
model
sepsi
hotchkiss
et
al
pancaspas
inhibitor
employ
treatment
liver
diseas
patient
hepat
c
pockro
et
al
howev
trial
target
caspas
proapoptot
molecul
administr
prosurviv
factor
eg
akt
activ
patient
sepsi
nosocomi
pneumonia
yet
report
review
de
fi
ned
clinic
featur
vap
describ
impact
critic
ill
microenviron
factor
introduc
mechan
ventil
suscept
vap
special
attent
speci
fi
c
molecul
potenti
mediat
immunosuppress
tissu
injuri
increas
microbi
resist
combin
burgeon
popul
patient
risk
trend
clearli
make
vap
major
clinic
problem
futur
prevent
strategi
optim
ventil
manag
paramount
reduc
incid
vap
howev
critic
illnessinduc
reprogram
leukocyt
innat
immun
respons
clearli
contribut
suscept
vap
vapinduc
tissu
injuri
given
past
failur
paradigm
shift
approach
patient
evid
immun
dysregul
requir
order
novel
therapi
proceed
better
clinic
marker
need
distinguish
deleteri
innat
respons
eg
sir
state
immunoparalysi
car
mix
antagonist
respons
syndrom
mar
fl
ammatori
respons
evolv
wesch
et
al
differenti
quit
dispar
overlap
respons
patientspeci
fi
c
fashion
allow
better
select
patient
immunoadjuv
therapi
like
bene
fi
cial
